Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52


A Rare Case of Triple-Negative Essential Thrombocythemia in a Young Postsplenectomy Patient: A Diagnostic Challenge.

Akcan T, Strati P, Yan M, Idowu M.

Case Rep Hematol. 2018 Dec 16;2018:9079462. doi: 10.1155/2018/9079462. eCollection 2018.


Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin Lymphoma.

Strati P, Patel S, Nastoupil L, Fanale MA, Bollard CM, Lin AY, Gordon LI.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):592-603. doi: 10.1200/EDBK_200549. Review.


ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study.

Strati P, Fanale MA, Oki Y, Turturro F, Fayad LE, Bartlett NL, Gladstone DE, Kasamon YL, Portlock CS, Wilson WH, Goy A, Younes A, Lee HJ.

Haematologica. 2019 Feb;104(2):e65-e67. doi: 10.3324/haematol.2018.199844. Epub 2018 Sep 6. No abstract available.


Renal complications of primary myelofibrosis.

Strati P, Glass WF, Abdelrahim M, Selamet U, Tchakarov A, Workeneh BT, Verstovsek S, Abudayyeh A.

Leuk Lymphoma. 2018 Jul 3:1-4. doi: 10.1080/10428194.2018.1474525. [Epub ahead of print] No abstract available.


Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia.

Strati P, Gabutti C, Thompson PA, Kontoyiannis DP, Ferrajoli A.

Leuk Lymphoma. 2018 Jun 18:1-3. doi: 10.1080/10428194.2018.1474527. [Epub ahead of print] No abstract available.


Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies.

Thompson PA, Peterson CB, Strati P, Jorgensen J, Keating MJ, O'Brien SM, Ferrajoli A, Burger JA, Estrov Z, Jain N, Kadia TM, Borthakur G, DiNardo CD, Daver N, Jabbour E, Wierda WG.

Leukemia. 2018 Nov;32(11):2388-2398. doi: 10.1038/s41375-018-0132-y. Epub 2018 Apr 17.


Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.

Autore F, Strati P, Laurenti L, Ferrajoli A.

Haematologica. 2018 Jun;103(6):931-938. doi: 10.3324/haematol.2017.186684. Epub 2018 May 10. Review.


Chronic Lymphocytic Leukemia: Diagnosis and Treatment.

Strati P, Jain N, O'Brien S.

Mayo Clin Proc. 2018 May;93(5):651-664. doi: 10.1016/j.mayocp.2018.03.002. Review.


A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

Strati P, Chihara D, Oki Y, Fayad LE, Fowler N, Nastoupil L, Romaguera JE, Samaniego F, Garg N, Feng L, Wesson ET, Ruben CE, Stafford MD, Nieto Y, Khouri IF, Hosing C, Horowitz SB, Kamble RT, Fanale MA.

Haematologica. 2018 Sep;103(9):e416-e418. doi: 10.3324/haematol.2018.187617. Epub 2018 Apr 5. No abstract available.


Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia.

Strati P, Ferrajoli A, Wierda WG, Jain N, Thompson PA, O'Brien SM, Rezvani K, Kantarjian HM, Burger JA, Hinojosa CO, Keating MJ, Estrov Z.

Leukemia. 2018 Oct;32(10):2278-2281. doi: 10.1038/s41375-018-0059-3. Epub 2018 Feb 20. No abstract available.


Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.

Takahashi K, Hu B, Wang F, Yan Y, Kim E, Vitale C, Patel KP, Strati P, Gumbs C, Little L, Tippen S, Song X, Zhang J, Jain N, Thompson P, Garcia-Manero G, Kantarjian H, Estrov Z, Do KA, Keating M, Burger JA, Wierda WG, Futreal PA, Ferrajoli A.

Blood. 2018 Apr 19;131(16):1820-1832. doi: 10.1182/blood-2017-11-817296. Epub 2018 Jan 22.


Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

Strati P, Fowler N, Pina-Oviedo S, Medeiros LJ, Overman MJ, Romaguera JE, Nastoupil L, Wang M, Hagemeister FB, Rodriguez A, Oki Y, Westin J, Turturro F, Neelapu SS, Fayad L.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e103-e108. doi: 10.1016/j.clml.2017.11.001. Epub 2017 Nov 14.


Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.

Boddu P, Masarova L, Verstovsek S, Strati P, Kantarjian H, Cortes J, Estrov Z, Pierce S, Pemmaraju N.

Ann Hematol. 2018 Jan;97(1):109-121. doi: 10.1007/s00277-017-3165-9. Epub 2017 Nov 15.


Myeloid/lymphoid neoplasms with FGFR1 rearrangement.

Strati P, Tang G, Duose DY, Mallampati S, Luthra R, Patel KP, Hussaini M, Mirza AS, Komrokji RS, Oh S, Mascarenhas J, Najfeld V, Subbiah V, Kantarjian H, Garcia-Manero G, Verstovsek S, Daver N.

Leuk Lymphoma. 2018 Jul;59(7):1672-1676. doi: 10.1080/10428194.2017.1397663. Epub 2017 Nov 9.


JAK2V617F detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosis.

Strati P, Benton CB, Manshouri T, Zhang Y, Bove JE 4th, Sanchez-Petitto G, Verstovsek S.

Leuk Res. 2017 Dec;63:53-55. doi: 10.1016/j.leukres.2017.10.016. Epub 2017 Oct 31.


Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia.

Strati P, Keating MJ, Burger JA, O'Brien SM, Wierda WG, Estrov Z, Zacharian G, Ferrajoli A.

Haematologica. 2017 Dec;102(12):e494-e496. doi: 10.3324/haematol.2017.171561. Epub 2017 Aug 10. No abstract available.


Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.

Strati P, Parikh SA, Chaffee KG, Kay NE, Call TG, Achenbach SJ, Cerhan JR, Slager SL, Shanafelt TD.

Br J Haematol. 2017 Aug;178(3):394-402. doi: 10.1111/bjh.14785. Epub 2017 Jun 4.


Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.

Jabbour E, Guastad Daver N, Short NJ, Huang X, Chen HC, Maiti A, Ravandi F, Cortes J, Abi Aad S, Garcia-Manero G, Estrov Z, Kadia T, O'Brien S, Dabaja B, Bueso-Ramos C, Strati P, Bivins C, Pierce S, Kantarjian H.

Am J Hematol. 2017 Sep;92(9):924-928. doi: 10.1002/ajh.24799. Epub 2017 Jul 19.


CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia.

Strati P, Parikh SA, Chaffee KG, Achenbach SJ, Slager SL, Call TG, Ding W, Jelinek DF, Hanson CA, Kay NE, Shanafelt TD.

Br J Haematol. 2017 Jul;178(1):99-105. doi: 10.1111/bjh.14647. Epub 2017 Apr 7.


Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance.

Strati P, Masarova L, Bose P, Daver N, Pemmaraju N, Verstovsek S.

Leuk Res. 2017 Jun;57:85-88. doi: 10.1016/j.leukres.2017.03.006. Epub 2017 Mar 8.


Treatment for relapsed or refractory chronic lymphocytic leukaemia: an ongoing challenge.

Strati P.

Lancet Haematol. 2017 Mar;4(3):e97-e98. doi: 10.1016/S2352-3026(17)30020-0. No abstract available.


Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.

Strati P, Bose P, Lyle L, Gaw K, Zhou L, Pierce SA, Huynh-Lu J, Hirsch-Ginsberg CF, Bueso-Mendoza DE, Bueso-Ramos CE, Verstovsek S.

Ann Hematol. 2017 May;96(5):733-738. doi: 10.1007/s00277-017-2956-3. Epub 2017 Feb 28.


65-Year-Old Man With Weight Loss and Progressive Acral Necrosis.

Ho TP, Strati P, Chon TY.

Mayo Clin Proc. 2017 Apr;92(4):605-608. doi: 10.1016/j.mayocp.2016.05.023. Epub 2017 Feb 24. No abstract available.


Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents.

Jabbour E, Strati P, Cabrero M, O'Brien S, Ravandi F, Bueso-Ramos C, Wei Q, Hu J, Abi Aad S, Short NJ, Dinardo C, Daver N, Kadia T, Wierda W, Wei Y, Colla S, Borthakur G, Cortes J, Estrov Z, Kantarjian H, Garcia-Manero G.

Am J Hematol. 2017 Apr;92(4):351-358. doi: 10.1002/ajh.24650. Epub 2017 Feb 13.


A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

Kay NE, Strati P, LaPlant BR, Leis JF, Nikcevich D, Call TG, Pettinger AM, Lesnick CE, Hanson CA, Shanafelt TD.

Oncotarget. 2016 Nov 29;7(48):78269-78280. doi: 10.18632/oncotarget.13412.


Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia.

Strati P, Chaffee KG, Achenbach SJ, Slager SL, Leung N, Call TG, Ding W, Parikh SA, Kay NE, Shanafelt TD.

Haematologica. 2017 Jan;102(1):e22-e25. doi: 10.3324/haematol.2016.150706. Epub 2016 Sep 15. No abstract available.


Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial.

Strati P, Lanasa M, Call TG, Leis JF, Brander DM, LaPlant BR, Pettinger AM, Ding W, Parikh SA, Hanson CA, Chanan-Khan AA, Bowen DA, Conte M, Kay NE, Shanafelt TD.

Lancet Haematol. 2016 Sep;3(9):e407-14. doi: 10.1016/S2352-3026(16)30064-3. Epub 2016 Aug 1.


Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis.

Parikh SA, Strati P, Tsang M, West CP, Shanafelt TD.

Blood. 2016 Apr 7;127(14):1752-60. doi: 10.1182/blood-2015-10-620864. Epub 2016 Feb 3. Review.


Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia.

Strati P, Uhm JH, Kaufmann TJ, Nabhan C, Parikh SA, Hanson CA, Chaffee KG, Call TG, Shanafelt TD.

Haematologica. 2016 Apr;101(4):458-65. doi: 10.3324/haematol.2015.136556. Epub 2016 Jan 27.


Solid organ transplant in individuals with monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.

Strati P, Gharaibeh KA, Leung N, Cosio FG, Call TG, Shanafelt TD.

Br J Haematol. 2016 Jul;174(1):162-5. doi: 10.1111/bjh.13759. Epub 2015 Oct 5. No abstract available.


Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience.

Strati P, Nasr SH, Leung N, Hanson CA, Chaffee KG, Schwager SM, Achenbach SJ, Call TG, Parikh SA, Ding W, Kay NE, Shanafelt TD.

Haematologica. 2015 Sep;100(9):1180-8. doi: 10.3324/haematol.2015.128793. Epub 2015 Jun 18.


Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Strati P, Shanafelt TD.

Blood. 2015 Jul 23;126(4):454-62. doi: 10.1182/blood-2015-02-585059. Epub 2015 Jun 11. Review.


Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia.

Strati P, Abruzzo LV, Wierda WG, O'Brien S, Ferrajoli A, Keating MJ.

Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):420-7. doi: 10.1016/j.clml.2015.02.001. Epub 2015 Feb 11.


Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.

Strati P, Kantarjian H, Ravandi F, Nazha A, Borthakur G, Daver N, Kadia T, Estrov Z, Garcia-Manero G, Konopleva M, Rajkhowa T, Durand M, Andreeff M, Levis M, Cortes J.

Am J Hematol. 2015 Apr;90(4):276-81. doi: 10.1002/ajh.23924. Epub 2015 Mar 2.


Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: a report on behalf of the MDS Clinical Research Consortium.

Jabbour EJ, Garcia-Manero G, Strati P, Mishra A, Al Ali NH, Padron E, Lancet J, Kadia T, Daver N, O'Brien S, Steensma DP, Sekeres MA, Gore SD, Dezern A, Roboz GJ, List AF, Kantarjian HM, Komrokji RS.

Cancer. 2015 Mar 15;121(6):876-82. doi: 10.1002/cncr.29145. Epub 2014 Nov 19.


A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia.

Strati P, Tong WG, Vitale C, Wierda WG, O'Brien S, Brown JR, Weng WK, Kipps T, Keating MJ, Ferrajoli A.

Leuk Lymphoma. 2015 Jun;56(6):1878-80. doi: 10.3109/10428194.2014.974049. Epub 2014 Nov 20. No abstract available.


Clinical significance of microcytosis in patients with primary myelofibrosis.

Strati P, Pemmaraju N, Estrov Z, Cardenas-Turanzas M, Pierce S, Newberry KJ, Daver N, Cortes J, Kantarjian H, Verstovsek S.

Leuk Res. 2014 Oct;38(10):1212-6. doi: 10.1016/j.leukres.2014.08.007. Epub 2014 Aug 28.


Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion.

Strati P, Keating MJ, O'Brien SM, Ferrajoli A, Burger J, Faderl S, Tambaro FP, Jain N, Wierda WG.

Haematologica. 2014 Aug;99(8):1350-5. doi: 10.3324/haematol.2014.104661. Epub 2014 May 23.


Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL.

Strati P, Keating MJ, O'Brien SM, Burger J, Ferrajoli A, Jain N, Tambaro FP, Estrov Z, Jorgensen J, Challagundla P, Faderl SH, Wierda WG.

Blood. 2014 Jun 12;123(24):3727-32. doi: 10.1182/blood-2013-11-538116. Epub 2014 Apr 4.


HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

Strati P, Kantarjian H, Thomas D, O'Brien S, Konoplev S, Jorgensen JL, Luthra R, Abruzzo L, Jabbour E, Quintas-Cardama A, Borthakur G, Faderl S, Ravandi F, Cortes J.

Cancer. 2014 Feb 1;120(3):373-80. doi: 10.1002/cncr.28433. Epub 2013 Oct 22.


Interaction between myelomonocytic and lymphoid cells in a patient with acute myelomonocytic leukemia and chronic lymphocytic leukemia.

Strati P, Manning JT, Ok CY, Garcia-Manero G, Estrov Z.

Leuk Lymphoma. 2014 Jun;55(6):1425-7. doi: 10.3109/10428194.2013.838234. Epub 2014 Jan 28. No abstract available.


Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemia.

Strati P, Daver N, Ravandi F, Pemmaraju N, Pierce S, Garcia-Manero G, Nazha A, Kadia T, Jabbour E, Borthakur G, Faderl S, Quintas-Cardama A, Kantarjian H, Cortes J.

Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S276-81. doi: 10.1016/j.clml.2013.05.020. Epub 2013 Aug 19.


Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.

Strati P, Wierda W, Burger J, Ferrajoli A, Tam C, Lerner S, Keating MJ, O'Brien S.

Cancer. 2013 Nov 1;119(21):3805-11. doi: 10.1002/cncr.28318. Epub 2013 Aug 13.


Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia.

Takahashi K, Pemmaraju N, Strati P, Nogueras-Gonzalez G, Ning J, Bueso-Ramos C, Luthra R, Pierce S, Cortes J, Kantarjian H, Garcia-Manero G.

Blood. 2013 Oct 17;122(16):2807-11; quiz 2920. doi: 10.1182/blood-2013-03-491399. Epub 2013 Jul 29.


Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemia.

Strati P, Ferrajoli A, Lerner S, O'Brien S, Wierda W, Keating MJ, Faderl S.

Leuk Lymphoma. 2014 Apr;55(4):828-33. doi: 10.3109/10428194.2013.819574. Epub 2013 Jul 29.


Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia.

Strati P, Keating MJ, Wierda WG, Badoux XC, Calin S, Reuben JM, O'Brien S, Kornblau SM, Kantarjian HM, Gao H, Ferrajoli A.

Blood. 2013 Aug 1;122(5):734-7. doi: 10.1182/blood-2013-04-495341. Epub 2013 Jun 25.


Long-term follow-up of patients with hypereosinophilic syndrome treated with Alemtuzumab, an anti-CD52 antibody.

Strati P, Cortes J, Faderl S, Kantarjian H, Verstovsek S.

Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):287-91. doi: 10.1016/j.clml.2012.09.018. Epub 2012 Nov 1.


TP53 mutation is rare in primary myelofibrosis.

Greaves WO, Verma S, Bisrat T, Strati P, Rahimi H, Paladugu AV, Luthra R, Patel KP, Medeiros LJ, Yao H, Pierce S, Bueso-Ramos CE, Verstovsek S.

Leuk Lymphoma. 2013 Jul;54(7):1552. doi: 10.3109/10428194.2012.745527. Epub 2012 Nov 30. No abstract available.


FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Daver N, Strati P, Jabbour E, Kadia T, Luthra R, Wang S, Patel K, Ravandi F, Cortes J, Qin Dong X, Kantarjian H, Garcia-Manero G.

Am J Hematol. 2013 Jan;88(1):56-9. doi: 10.1002/ajh.23345. Epub 2012 Oct 31.

Supplemental Content

Loading ...
Support Center